| ISIN | LU1169821375 |
|---|---|
| Valorennummer | 26750014 |
| Bloomberg Global ID | |
| Fondsname | UBS (Lux) Fund Solutions – UBS MSCI United Kingdom UCITS ETF hUSD dis |
| Fondsanbieter |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fondsanbieter | UBS Asset Management Switzerland AG, Zurich |
| Vertreter in der Schweiz |
UBS Fund Management (Switzerland) AG Basel Telefon: +41 61 288 49 10 |
| Distributor(en) |
UBS AG Basel Telefon: +41 61 288 20 20 UBS AG, Zürich Zürich Telefon: +41 44 234 11 11 |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | Equity United Kingdom |
| Anteilskategorie | Distribution |
| Domizilland | Luxemburg |
| Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
| Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
| Investment-Strategie *** | The sub-fund aims to track, before expenses, the price and income performance of the price of the MSCI United Kingdom Index (Net Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant. |
| Besonderheiten |
| Aktueller Preis * | 6.50 USD | 29.10.2025 |
|---|---|---|
| Vorheriger Preis * | 6.45 USD | 28.10.2025 |
| 52 Wochen Hoch * | 6.50 USD | 29.10.2025 |
| 52 Wochen Tief * | 5.05 USD | 09.04.2025 |
| NAV * | 6.50 USD | 29.10.2025 |
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 4'063'483'178 | |
| Anteilsklassevermögen *** | 8'800'317 | |
| Trading Information SIX | ||
| YTD-Performance | +22.42% |
31.12.2024 - 29.10.2025
31.12.2024 29.10.2025 |
|---|---|---|
| YTD-Performance (in CHF) | +7.85% |
31.12.2024 - 29.10.2025
31.12.2024 29.10.2025 |
| 1 Monat | +5.09% |
29.09.2025 - 29.10.2025
29.09.2025 29.10.2025 |
| 3 Monate | +7.80% |
29.07.2025 - 29.10.2025
29.07.2025 29.10.2025 |
| 6 Monate | +16.69% |
29.04.2025 - 29.10.2025
29.04.2025 29.10.2025 |
| 1 Jahr | +22.16% |
29.10.2024 - 29.10.2025
29.10.2024 29.10.2025 |
| 2 Jahre | +39.05% |
15.11.2023 - 29.10.2025
15.11.2023 29.10.2025 |
| 3 Jahre | - | - |
| 5 Jahre | - | - |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 8.77% | |
|---|---|---|
| HSBC Holdings PLC | 7.91% | |
| Shell PLC | 7.58% | |
| Unilever PLC | 5.19% | |
| Rolls-Royce Holdings PLC | 4.28% | |
| British American Tobacco PLC | 3.67% | |
| BP PLC | 3.12% | |
| GSK PLC | 2.99% | |
| RELX PLC | 2.91% | |
| Rio Tinto PLC Ordinary Shares | 2.72% | |
| Letzte Daten-Aktualisierung | 24.10.2025 | |
| TER | 0.23% |
|---|---|
| Datum TER | 30.06.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.23% |
| Ongoing Charges *** | 0.23% |
|
SRRI ***
|
|
| Datum SRRI *** | 29.02.2024 |